Skip to main content

GeneDx Holdings Corp.

WGS
Exchange
Nasdaq
Industry
Services-Health Services
SEC CIK
0001818331

In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding GeneDx Holdings Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of WGS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders111198−12
Shares161.0M62.2K158.3M−2.63M (−1.6%)
Value$201.7M$78.3K$138.1M−$63.4M (−31.5%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held GeneDx Holdings Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to WGS in Q3 2022
InstitutionSharesValue% of portfolio
Alpine Global Management, LLC110,253$97.0K0.02%
Two Sigma Securities, LLC45,252$40.0K0.01%
Eqis Capital Management, Inc.12,493$11.0K0.00%
Ionic Capital Management LLC2,554$2.00K0.00%
Clear Street Markets LLC408$00.00%
Allworth Financial LP60$00.00%
Capital Advisors, Ltd. LLC63$00.00%

Sold out (19)

Institutions that held GeneDx Holdings Corp. at the end of Q2 2022 and filed for Q3 2022 without it.

Not filed for Q3 2022 yet (1)

Institutions that held GeneDx Holdings Corp. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding WGS in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Exane Derivatives62,153$78.3K